Elena Schiopu

Elena Schiopu serves as Professor and Director of Continuing Medical Education at Augusta University's Medical College of Georgia within the Department of Medicine, Rheumatology division. Board-certified in Rheumatology by the American Board of Internal Medicine, she maintains active medical licensure in Georgia and Michigan with DEA authorization.

Her educational foundation includes:

• MD from Universitatea De Medicina Si F (1997)
• ECFMG certification (1999)
• DEA License (2003)
• American Board of Internal Medicine, Rheumatology (2005)
• Georgia Composite Medical Board License (2022)

Dr. Schiopu's research centers on complex autoimmune rheumatic diseases with emphasis on systemic sclerosis, anti-synthetase syndrome, psoriatic arthritis, and dermatomyositis. Her work integrates clinical trial design, biomarker validation, and therapeutic safety assessment to address unmet needs in connective tissue disorders. She actively investigates novel biologics and immunomodulators for refractory cases.

Her 2024 publications reveal a cohesive research trajectory focused on advancing diagnostic precision and treatment paradigms in rare rheumatic conditions. Key themes include biomarker-driven systemic sclerosis management, standardized anti-synthetase syndrome classification, biologic efficacy across psoriatic arthritis phenotypes, and IVIG safety in dermatomyositis. These studies collectively demonstrate translational rigor through multicenter collaborations and rigorous trial designs.

Notable recognitions include:

• Token of Appreciation from Medical Students (TAMS) Award (2020)
• 2017 ACR/EULAR Exchange Program participation
• Exemplar recognition by The University of Michigan Medical School's Learning Environment Task Force (2017)

As Director of Clinical Trials and committee member for fellowship evaluations, she shapes rheumatology training while advancing evidence-based practice. Her NIH-funded IMACS collaboration and Georgia Society of Rheumatology leadership reflect institutional impact beyond direct patient care.

Dr. Schiopu co-leads the NIH NIEHS International Myositis Assessment & Clinical Studies Group while directing clinical trials infrastructure. Her work with the ProDERM study team and ACR guideline panels establishes her as a key contributor to national rheumatology research consortia.